Presentation is loading. Please wait.

Presentation is loading. Please wait.

Biostat 215 Clarifying the Causal Question Thomas B. Newman, MD, MPH.

Similar presentations


Presentation on theme: "Biostat 215 Clarifying the Causal Question Thomas B. Newman, MD, MPH."— Presentation transcript:

1 Biostat 215 Clarifying the Causal Question Thomas B. Newman, MD, MPH

2 Take-home message n In order to know how to get the answer, you need to be clear on the question n Often this means not only what question is being asked, but why it is important. What decisions might be affected by the results?

3 Examples n Phototherapy for newborns n TPA and death in stroke patients (Kurth) –Different models addressed effect of TPA on different groups of patients n MSM for effect of ASA on CV mortality (Cook) –Total Effect ASA, including benefit from starting after ASA after MI n Hormone Replacement Therapy in nurses to prevent CV mortality (Hernan) –Effect of starting vs being on HRT

4 New Example: Cerebral Palsy n A group of nonprogressive disorders of movement and posture caused by abnormal development of, or damage to, motor control centers of the brain. n Incidence about 2/1000 live births n One (uncommon) cause is kernicterus. n RQ: What are risk factors for cerebral palsy in the Northern CA Kaiser Permanente Medical Care Program? Late Impact of Getting Hyperbilirubinemia or photoTherapy

5 Late Impact of Getting Hyperbilirubinemia or photoTherapy (LIGHT) Study n Design: Historical cohort n Subjects: 573,899 newborns born alive 1995- 2011 n Predictor variables: hospital, prenatal, perinatal variables from electronic record n Outcome: CP, obtained from diagnoses in KP Virtual Data Warehouse (VDW) or California Dept of Developmental Services (DDS), confirmed by chart review by child neurologist

6 ?What variables should I include/control for? n Facility? n Mother’s education? n Gestational age? n Birth weight?

7 I am interested in PREVENTABLE causes of CP n Particular interest in differences by facility, since there may be practice differences leading to differences in CP n Should I control for birth weight? n Should I control for gestational age?

8 Depends on perspective, i.e., what interventions are envisioned n Pediatrics n Obstetrics n Public health n Starting with live births (especially ≥ 35 wks gestation) already reflects a pediatric perspective! n Starting with pregnancies reflects an obstetric prespective

9 Course review


Download ppt "Biostat 215 Clarifying the Causal Question Thomas B. Newman, MD, MPH."

Similar presentations


Ads by Google